UBS maintains Buy rating on Teva Pharmaceuticals
UBS maintained a Buy rating on Teva Pharmaceuticals, according to Benzinga ratings actions.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.